Larvol Delta - Completed-Successful-EndofPhase-2-quotEoP2-Meeting-with-FDA-and-Advanced-Phase-3-Readiness-Activities

onvansertib (PCM-075) - Cardiff Oncology

https://www.manilatimes.net/2026/08/12/tmt-newswire/globenewswire/cardiff-oncology-reports-second-quarter-2026-results-and-provides-business-update/2403459/amp

Aug 12, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next